Megan Boston
2024
In 2024, Megan Boston earned a total compensation of $1.3M as Executive Director at Benitec Biopharma, a 172% increase compared to previous year.
Compensation breakdown
| Option Awards | $914,418 |
|---|---|
| Salary | $344,541 |
| Other | $18,038 |
| Total | $1,276,997 |
Boston received $914.4K in option awards, accounting for 72% of the total pay in 2024.
Boston also received $344.5K in salary and $18K in other compensation.
Rankings
In 2024, Megan Boston's compensation ranked 43rd out of 207 executives tracked by ExecPay. In other words, Boston earned more than 79.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 43 out of 207 | 79th |
Division Manufacturing | 12 out of 89 | 87th |
Major group Chemicals And Allied Products | 4 out of 36 | 89th |
Industry group Drugs | 4 out of 33 | 88th |
Industry Pharmaceutical Preparations | 3 out of 30 | 90th |
Source: SEC filing on October 23, 2024.
Boston's colleagues
We found one more compensation record of an executive working with Megan Boston at Benitec Biopharma in 2024.
2024
Jerel Banks
Benitec Biopharma